Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report

Sahin Bodur; Yetis Isildar; Halil Kara; Murat Sabanci

doi:doi:10.11648/j.ajpn.20140206.16

| Peer-Reviewed

Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report

Sahin Bodur, Yetis Isildar, Halil Kara, Murat Sabanci

Published in American Journal of Psychiatry and Neuroscience (Volume 2, Issue 6)

Received: 15 December 2014 Accepted: 22 December 2014 Published: 27 December 2014

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.

Published in	American Journal of Psychiatry and Neuroscience (Volume 2, Issue 6)
DOI	10.11648/j.ajpn.20140206.16
Page(s)	115-117
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2014. Published by Science Publishing Group

Keywords

ADHD, Stuttering, Psychostimulants, Treatment

References

[1]	Kotte A, Faraone SV, Biederman J. Association of genetic risk severity with ADHD clinical characteristics. Am J Med Genet B Neuropsychiatr Genet. 2013;7:718-33.
[2]	Generali JA, Cada DJ. Risperidone: Stuttering. Hosp Pharm. 2014; 49:242-3.
[3]	Devroey D, Beerens G,Van De Vijver E. Methylphenidate as a treatment for stuttering: a case report. Eur Rev Med Pharmacol Sci. 2012;16: 66-69
[4]	Shaygannejad V, Khatoonabadi SA , Shafiei B, Ghasemi M, Fatehi F, Meamar R et al. Olanzapine Versus Haloperidol: Which Can Control Stuttering Better? Int J Prev Med. May 2013; 4: 270–273.
[5]	Donaher J, Richels C. Traits of attention deficit/hyperactivity disorder in school-age children who stutter. J Fluency Disord. 2012;37:242-52.
[6]	Arnsten AF, Wang MJ, Paspalas CD. Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron. 2012; 76:223-39.
[7]	Arnsten AF. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry. 2011;15;69:89-99.
[8]	Arnsten AF, Pliszka SR. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav. 2011;99:211-6.

Cite This Article

Plain Text BibTeX RIS

APA Style

Sahin Bodur, Yetis Isildar, Halil Kara, Murat Sabanci. (2014). Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. American Journal of Psychiatry and Neuroscience, 2(6), 115-117. https://doi.org/10.11648/j.ajpn.20140206.16

Copy | Download

ACS Style

Sahin Bodur; Yetis Isildar; Halil Kara; Murat Sabanci. Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. Am. J. Psychiatry Neurosci. 2014, 2(6), 115-117. doi: 10.11648/j.ajpn.20140206.16

Copy | Download

AMA Style

Sahin Bodur, Yetis Isildar, Halil Kara, Murat Sabanci. Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. Am J Psychiatry Neurosci. 2014;2(6):115-117. doi: 10.11648/j.ajpn.20140206.16

Copy | Download

@article{10.11648/j.ajpn.20140206.16,
  author = {Sahin Bodur and Yetis Isildar and Halil Kara and Murat Sabanci},
  title = {Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report},
  journal = {American Journal of Psychiatry and Neuroscience},
  volume = {2},
  number = {6},
  pages = {115-117},
  doi = {10.11648/j.ajpn.20140206.16},
  url = {https://doi.org/10.11648/j.ajpn.20140206.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpn.20140206.16},
  abstract = {Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.},
 year = {2014}
}

Copy | Download

TY  - JOUR
T1  - Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report
AU  - Sahin Bodur
AU  - Yetis Isildar
AU  - Halil Kara
AU  - Murat Sabanci
Y1  - 2014/12/27
PY  - 2014
N1  - https://doi.org/10.11648/j.ajpn.20140206.16
DO  - 10.11648/j.ajpn.20140206.16
T2  - American Journal of Psychiatry and Neuroscience
JF  - American Journal of Psychiatry and Neuroscience
JO  - American Journal of Psychiatry and Neuroscience
SP  - 115
EP  - 117
PB  - Science Publishing Group
SN  - 2330-426X
UR  - https://doi.org/10.11648/j.ajpn.20140206.16
AB  - Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.
VL  - 2
IS  - 6
ER  -

Copy | Download

Author Information

Sahin Bodur

Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey
Yetis Isildar

Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey
Halil Kara

Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey
Murat Sabanci

Child and Adolescent Psychiatry, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Sahin Bodur, Yetis Isildar, Halil Kara, Murat Sabanci. (2014). Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. American Journal of Psychiatry and Neuroscience, 2(6), 115-117. https://doi.org/10.11648/j.ajpn.20140206.16

Copy | Download

ACS Style

Sahin Bodur; Yetis Isildar; Halil Kara; Murat Sabanci. Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. Am. J. Psychiatry Neurosci. 2014, 2(6), 115-117. doi: 10.11648/j.ajpn.20140206.16

Copy | Download

AMA Style

Sahin Bodur, Yetis Isildar, Halil Kara, Murat Sabanci. Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report. Am J Psychiatry Neurosci. 2014;2(6):115-117. doi: 10.11648/j.ajpn.20140206.16

Copy | Download

@article{10.11648/j.ajpn.20140206.16,
  author = {Sahin Bodur and Yetis Isildar and Halil Kara and Murat Sabanci},
  title = {Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report},
  journal = {American Journal of Psychiatry and Neuroscience},
  volume = {2},
  number = {6},
  pages = {115-117},
  doi = {10.11648/j.ajpn.20140206.16},
  url = {https://doi.org/10.11648/j.ajpn.20140206.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpn.20140206.16},
  abstract = {Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.},
 year = {2014}
}

Copy | Download

TY  - JOUR
T1  - Effectiveness of Osmotic-Controlled Release Oral Delivery System Methylphenidate in the Treatment of Stuttering that Combined with Attention-Deficit/Hyperactivity Disorder: A Case Report
AU  - Sahin Bodur
AU  - Yetis Isildar
AU  - Halil Kara
AU  - Murat Sabanci
Y1  - 2014/12/27
PY  - 2014
N1  - https://doi.org/10.11648/j.ajpn.20140206.16
DO  - 10.11648/j.ajpn.20140206.16
T2  - American Journal of Psychiatry and Neuroscience
JF  - American Journal of Psychiatry and Neuroscience
JO  - American Journal of Psychiatry and Neuroscience
SP  - 115
EP  - 117
PB  - Science Publishing Group
SN  - 2330-426X
UR  - https://doi.org/10.11648/j.ajpn.20140206.16
AB  - Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.
VL  - 2
IS  - 6
ER  -

Copy | Download